These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 21320446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Facilitated cross-bridge interactions with thin filaments by familial hypertrophic cardiomyopathy mutations in α-tropomyosin.
    Wang F, Brunet NM, Grubich JR, Bienkiewicz EA, Asbury TM, Compton LA, Mihajlović G, Miller VF, Chase PB.
    J Biomed Biotechnol; 2011; 2011():435271. PubMed ID: 22187526
    [Abstract] [Full Text] [Related]

  • 8. Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin.
    Ly S, Lehrer SS.
    Biochemistry; 2012 Aug 14; 51(32):6413-20. PubMed ID: 22794249
    [Abstract] [Full Text] [Related]

  • 9. The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy.
    Li XE, Suphamungmee W, Janco M, Geeves MA, Marston SB, Fischer S, Lehman W.
    Biochem Biophys Res Commun; 2012 Aug 03; 424(3):493-6. PubMed ID: 22789852
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants.
    Davis J, Wen H, Edwards T, Metzger JM.
    J Mol Cell Cardiol; 2008 May 03; 44(5):891-904. PubMed ID: 18423659
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
    Michele DE, Gomez CA, Hong KE, Westfall MV, Metzger JM.
    Circ Res; 2002 Aug 09; 91(3):255-62. PubMed ID: 12169652
    [Abstract] [Full Text] [Related]

  • 17. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.
    Coutu P, Bennett CN, Favre EG, Day SM, Metzger JM.
    Circ Res; 2004 May 14; 94(9):1235-41. PubMed ID: 15059934
    [Abstract] [Full Text] [Related]

  • 18. Effects of tropomyosin internal deletion Delta23Tm on isometric tension and the cross-bridge kinetics in bovine myocardium.
    Lu X, Tobacman LS, Kawai M.
    J Physiol; 2003 Dec 01; 553(Pt 2):457-71. PubMed ID: 14500764
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
    Karibe A, Tobacman LS, Strand J, Butters C, Back N, Bachinski LL, Arai AE, Ortiz A, Roberts R, Homsher E, Fananapazir L.
    Circulation; 2001 Jan 02; 103(1):65-71. PubMed ID: 11136687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.